Population
Patients treated with potentially cardiotoxic cancer therapy
Design
Guideline
Authors
Loading...
Highlights shared CVD-cancer burden in survivors; leaves open need for prospective cardio-oncology trials before practice change.
This consensus document outlines practical recommendations for the multidisciplinary cardio-oncology management of patients receiving potentially cardiotoxic cancer therapies.
Tarantini et al. (2017) conducted a review in Cancer and cardiovascular disease. Cardio-oncology clinical and management pathways was evaluated. This consensus document provides practical recommendations for the assessment, monitoring, and treatment of patients receiving potentially cardiotoxic cancer therapies to minimize cardiac toxicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: